Summary
As large-volume subcutaneous therapies increase in volume and viscosity, delivery systems must balance injection performance with device size, spring force, and usability. This poster explores how SHL Medical’s Needle Isolation Technology (NIT), integrated within the Magnitude autoinjector platform, can enhance delivery performance through its modular fluid-path architecture. In a test setup comparing single- and split-cannula approaches, analytical modelling and empirical testing of representative 5.0 mL injections showed that the split-cannula design reduces fluidic resistance, enabling more than 50% faster delivery across the tested viscosity range of 10, 20, and 30 cP. This work was presented at the 2026 Parenteral Drug Association (PDA) Universe of Prefilled Syringes and Injection Devices conference.
Key takeaways
- The NIT split-cannula design achieved more than 50% faster delivery across the tested viscosities of 10, 20, and 30 cP at a 5.0 mL injection volume.
- NIT decouples fluid-path design from the primary container, allowing flow characteristics to be optimized without fundamental changes to the Magnitude powerpack or cartridge architecture.
- Experimental injection-time results aligned closely with mathematical modelling, supporting the use of predictive modelling to evaluate additional viscosities and design configurations.
Document details
- Format: Scientific poster
- Authors: M. Klebunde et al.
- Speaker: Vince Masciopinto, Customer Solutions Director
- Page count: 1 page
- Estimated read time: 5-10 minutes